Towards Healthcare

SEARCH RESULT FOR

Lipid Nanoparticles

November 01, 2025

Lipid Nanoparticles Market Trends and Opportunities for Pharma & Biotech Firms

  • Status : Published
  • No. of Pages: 150+
  • Category : Healthcare Services

According to market projections, the global lipid nanoparticles market, valued at USD 1.04 billion in 2024, is anticipated to reach USD 3.84 billion by 2034, growing at a CAGR of 13.97% over the next decade. In 2024, North America led the global lipi...

November 05, 2025

Lipid Regulators Market Advances with Next Gen Statin Alternatives

  • Status : Published
  • No. of Pages: 150+
  • Category : Therapeutic Area

According to market projections, the lipid regulators sector is expected to grow from USD 33.65 billion in 2025 to USD 49.96 billion by 2035, reflecting a CAGR of 4.04%. The market is growing due to the rising prevalence of cardiovascular diseases an...

November 01, 2025

Lipid Nanoparticle Manufacturing Market Size and Competitive Strategies

  • Status : Published
  • No. of Pages: 150+
  • Category : Therapeutic Area

Market insights predict the global lipid nanoparticle manufacturing industry will increase from USD 400 million in 2024 to USD 2243 million by 2034, achieving a CAGR of 18.9%. The lipid nanoparticle manufacturing market is expanding due to the rising...

November 28, 2025

Lipid Nanoparticle Raw Materials Market Size and Innovations Driving the Drug Delivery

  • Status : Published
  • No. of Pages: 150+
  • Category : Biotechnology

According to forecasts, the global lipid nanoparticle raw materials market will grow from USD 300.72 million in 2025 to USD 522.01 million by 2035, with an expected CAGR of 5.67%. The need for better drug delivery systems for enhanced performance dri...

November 01, 2025

Hyperlipidemia Drugs Market Key Trends & Strategic Imperatives

  • Status : Published
  • No. of Pages: 150+
  • Category : Therapeutic Area

According to market projections, the hyperlipidemia drugs sector is expected to grow from USD 24.47 billion in 2025 to USD 31.49 billion by 2034, reflecting a CAGR of 2.84%. In 2024, North America led the global hyperlipidemia drugs market, with stat...